Houlihan Lokey, Inc. (HLI) Price Prediction 2026–2050

Houlihan Lokey, Inc. is an investment banking company that provides merger and acquisition (M&A), capital market, financial restructurings and liability management, and financial and valuation advisory services worldwide. The company operates in three segments: Corporate Finance (CF), Financial Restructuring (FR), and Financial and Valuation Advisory (FVA).

The CF segment offers general financial advisory services; and advises public and private institutions, including financial sponsors on buy-side and sell-side M&A transactions, debt and equity financings in both the private and public markets, and other corporate finance transactions.

The FR segment advises debtors, creditors, and other parties-in-interest related to recapitalization/deleveraging transactions. This segment also provides a range of advisory services, such as structuring, negotiation, and confirmation of plans of reorganization; structuring and analysis of exchange offers; liability management transactions; corporate viability assessment; dispute resolution and expert testimony; and procuring debtor-in-possession financing.

The FVA segment provides valuation services to companies; debt and equity interests comprising illiquid investments; and other assets and liabilities. This segment also offers fairness opinions in connection with mergers and acquisitions and other transactions; solvency opinions in connection with corporate spin-offs and dividend recapitalizations; other types of financial opinions; and diligence, tax, transaction accounting, and other financial advisory services, as well as dispute resolution services. Houlihan Lokey, Inc.

was incorporated in 1972 and is headquartered in Los Angeles, California.

Houlihan Lokey, Inc. (HLI) trades at $128.34 per share and has a market capitalization of $8.97B, ranking 915. The current price sits amid a near-term technical picture that shows bearish momentum, with a price set against near-term support and resistance levels.

The overall price outlook from the provided forecast suggests a bullish trajectory beginning in the late 2020s and extending through 2050, with substantial upside in several years.

The stock’s near-term setup places emphasis on the $128.34 support and $145.47 resistance, while the 30-day range runs from $111.65 to $147.52. The SMA50 sits at $140.21 and the SMA200 at $161.39, with RSI at 40 and annualized volatility around 40%, indicating meaningful downside pressure in the short term but potential for longer-term upside.

The multi-year forecast shows a path from neutral to bullish across the horizon. For 2026, the min and the avg are both $128.34 with a max of $169.65 and an ROI of 0, indicating a neutral near-term baseline. From 2027 onward the outlook improves, with 2027 averaging $165.62 and a max of $213.37 (ROI 29.1%), 2028 averaging $178.21 and a max of $236.59 (ROI 38.9%), and 2029 averaging $197.59 with a max of $268.56 (ROI 54%).

By 2030 the average is projected at $200.37 with a max of $277.79 (ROI 56.1%), and sentiment remains BULLISH. The forecast continues to rise through 2031–2035, and into 2040 with an average of $490.01 and a max of $768.80 (ROI 281.8%), and by 2050 an average of $849.98 with a max of $1,438.27 (ROI 562.3%), all with bullish sentiment. These figures illustrate a sustained long-term upside, though they are estimates and not guarantees.